跳至主要内容
临床试验/NCT03433209
NCT03433209已完成不适用

Electrosurgery Wars;Ligasure or Enseal in Total Laparoscopic Hysterectomy: A Randomised Controlled Trial

Antalya Training and Research Hospital0 个研究点目标入组 134 人开始时间: 2016年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
134
主要终点
Operative time

研究概览

简要总结

The effect of two different bipolar instruments were compared in terms of operative time, total operative time, intra-operative blood loss and intra-operative and postoperative complications. Devices included the LigaSure™ Maryland Jaw 5 mm laparoscopic instrument (LigaSure; LF 1737, Covidien, Mansfield, MA, USA) and ENSEAL™ G2 Articulating Straight 5mm Tissue Sealer (ENSEAL; NSLG2S35A, Ethicon Endo-surgery, US, LLC).

详细描述

This study is a single-center, single-blinded, randomized control trial that was conducted at the University of Health Sciences Antalya Training and Research Hospital.

The study was single-blinded in that the patient was not informed of their group assignment; it is impossible to blind the surgeon using the devices.

Methods and Procedures:

Patients were recruited from outpatient clinics and informed about the study before enrollment. Women aged over 18 years scheduled for laparoscopic hysterectomy for benign indications between June 2016 and November 2017 were included in the study after obtaining written consent.

Women who had given consent were randomized one day before surgery to one of two groups:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18 or older
  • Able and willing to provide informed consent
  • Undergoing total laparoscopic hysterectomy

排除标准

  • Under 18 years of age
  • Suspected malignancy

研究组 & 干预措施

Ligasure device

Active Comparator

This group of women undergoing hysterectomy were randomized to the Ligasure energy device

干预措施: Ligasure device (Device)

Articulating Enseal

Active Comparator

This group of women undergoing hysterectomy were randomized to the articulating Enseal energy device

干预措施: Articulating Enseal (Device)

结局指标

主要结局

Operative time

时间窗: 16 months

Defined as time from start of sealing and transection of the round ligament until start of colpotomy, was the primary endpoint.

次要结局

  • Total operative time(16 months)
  • Intra-operative complications(16 months)
  • Intra-operative estimated blood loss(16 months)

研究者

发起方
Antalya Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Burak Karadag, MD

Associate Professor

Antalya Training and Research Hospital

相似试验